Women's Health Collection

Journal article

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer

Abstract:: Background. The Collaborative Group on Hormonal Factors in Breast Cancer has brought together and reanalysed about 90% of the worldwide epidemiological evidence on the relation between risk of breast cancer and use of hormone replacement therapy (HRT). Methods. Individual data on 52,705 women with breast cancer and 108,411 women without breast cancer from 51 studies in 21 countries were collected, checked, and analysed centrally. The main analyses are based on 53,865 postmenopausal women with...
Expand abstract
Collapse abstract

Publication status:: Published

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Beral, V., Bull, D., Doll, R., Key, T., Peto, R., Reeves, G., Calle, E., Heath, C., Coates, R., Liff, J., Franceschi, S., Talamini, R., Chantarakul, N., Koetsawang, S., Rachawat, D., Morabia, A., Schuman, L., Stewart, W., Szklo, M., … Gallagher, R. (1997). Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. LANCET, 350(9084), 1047–1059.

MLA Style

Beral, V, et al. “Breast Cancer and Hormone Replacement Therapy: Collaborative Reanalysis of Data from 51 Epidemiological Studies of 52,705 Women with Breast Cancer and 108,411 Women without Breast Cancer.” LANCET, vol. 350, no. 9084, 1997, pp. 1047–59.

Chicago Style

Beral, V, D Bull, R Doll, et al. 1997. “Breast Cancer and Hormone Replacement Therapy: Collaborative Reanalysis of Data from 51 Epidemiological Studies of 52,705 Women with Breast Cancer and 108,411 Women without Breast Cancer.” LANCET 350 (9084): 1047–59.
Print

Access Document

Publisher copy:: 10.1016/S0140-6736(97)08233-0

Authors

+ Beral, V More by this author

Institution:: University of Oxford
Division:: MSD
Department:: Nuffield Department of Population Health
Sub department:: Cancer Epidemiology Unit
Role:: Author

+ Bull, D More by this author

Role:: Author

+ Doll, R More by this author

Role:: Author

+ Key, T More by this author

Role:: Author

+ Peto, R More by this author

Institution:: University of Oxford
Division:: MSD
Department:: Nuffield Department of Population Health
Sub department:: Clinical Trial Service Unit
Role:: Author

More authors...

Journal:: LANCET More from this journal
Volume:: 350
Issue:: 9084
Pages:: 1047-1059
Publication date:: 1997-10-11
DOI:: 10.1016/S0140-6736(97)08233-0
ISSN:: 0140-6736

Language:: English
Pubs id:: pubs:7358
UUID:: uuid:1b81f09d-d37a-4646-8acf-b9236a9316a7
Local pid:: pubs:7358
Source identifiers:: 7358
Deposit date:: 2012-12-19
ARK identifier:: ark:/29072/ora_1b81f09dd37a46468acfb9236a9316a7

Terms of use

Copyright date:: 1997

Licence:: Terms and Conditions of Use for Oxford University Research Archive

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP